|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
US6182712B1
(en)
|
1997-07-21 |
2001-02-06 |
Inhale Therapeutic Systems |
Power filling apparatus and methods for their use
|
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
|
HUP0105089A3
(en)
*
|
1998-11-20 |
2002-09-30 |
Skyepharma Canada Inc |
Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles
|
|
FR2795961B1
(fr)
*
|
1999-07-09 |
2004-05-28 |
Ethypharm Lab Prod Ethiques |
Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
|
|
US7863331B2
(en)
*
|
1999-07-09 |
2011-01-04 |
Ethypharm |
Pharmaceutical composition containing fenofibrate and method for the preparation thereof
|
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
|
US7049146B2
(en)
|
2000-11-14 |
2006-05-23 |
Facet Analytical Services And Technology, Llc |
Calibration standards, methods, and kits for water determination
|
|
US7122376B2
(en)
*
|
2001-11-01 |
2006-10-17 |
Facet Analytical Services And Technology, Llc |
Calibration standards, methods, and kits for water determination
|
|
GB0028429D0
(en)
*
|
2000-11-22 |
2001-01-10 |
Astrazeneca Ab |
Therapy
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US6607784B2
(en)
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6977085B2
(en)
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
CA2461349C
(en)
|
2001-09-26 |
2011-11-29 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
WO2003088951A1
(en)
*
|
2002-04-15 |
2003-10-30 |
Eiffel Technologies Limited |
Formulation of fine particles using liquefied or dense gases
|
|
NO346970B1
(no)
*
|
2002-05-24 |
2023-03-20 |
Alkermes Pharma Ireland Ltd |
Nanopartikulære fiberformuleringer
|
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
JP4831965B2
(ja)
*
|
2002-06-10 |
2011-12-07 |
エラン ファーマ インターナショナル,リミティド |
HMG−CoA還元酵素インヒビター誘導体(「スタチン」)を含むナノ粒子製剤、その新規組合せ、ならびにこれらの医薬組成物の製造
|
|
TW200404544A
(en)
*
|
2002-06-17 |
2004-04-01 |
Kowa Co |
Controlled release pharmaceutical composition
|
|
WO2004002827A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Nektar Therapeutics |
Device and method for controlling the flow of a powder
|
|
PL377847A1
(pl)
|
2003-01-14 |
2006-02-20 |
Arena Pharmaceuticals Inc. |
1,2,3-Tripodstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie związanych z nim zaburzeń takich jak cukrzyca i hiperglikemia
|
|
EP1631496B1
(de)
|
2003-04-28 |
2014-02-26 |
Medical Instill Technologies, Inc. |
Behälter mit ventilanordnung zum füllen und abgeben von stoffen und vorrichtung und verfahren zum füllen
|
|
US20040241252A1
(en)
*
|
2003-05-29 |
2004-12-02 |
Abney Christopher Charles |
Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
|
|
KR20060056944A
(ko)
|
2003-07-14 |
2006-05-25 |
아레나 파마슈티칼스, 인크. |
대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료
|
|
US20050096391A1
(en)
*
|
2003-10-10 |
2005-05-05 |
Per Holm |
Compositions comprising fenofibrate and rosuvastatin
|
|
US9173847B2
(en)
*
|
2003-10-10 |
2015-11-03 |
Veloxis Pharmaceuticals A/S |
Tablet comprising a fibrate
|
|
MXPA06003813A
(es)
*
|
2003-10-10 |
2006-06-14 |
Lifecycle Pharma As |
Forma solida de dosificacion que comprende un fibrato y una estatina.
|
|
KR20130103818A
(ko)
*
|
2003-10-10 |
2013-09-24 |
벨로시스 파마슈티컬스 에이/에스 |
피브레이트를 포함하는 고형 제제
|
|
US20050096390A1
(en)
*
|
2003-10-10 |
2005-05-05 |
Per Holm |
Compositions comprising fenofibrate and pravastatin
|
|
CA2543596A1
(en)
*
|
2003-11-07 |
2005-05-26 |
Jj Pharma, Inc. |
Hdl-boosting combination therapy complexes
|
|
US7611630B2
(en)
*
|
2004-03-30 |
2009-11-03 |
Bend Research, Inc. |
Method and device for evaluation of pharmaceutical compositions
|
|
CN1933816A
(zh)
*
|
2004-03-30 |
2007-03-21 |
史密丝克莱恩比彻姆公司 |
喷雾干燥的药物组合物
|
|
US7101585B2
(en)
*
|
2004-04-15 |
2006-09-05 |
Solae, Llc |
Ultra high pressure homogenization process for making a stable protein based acid beverage
|
|
US7306562B1
(en)
*
|
2004-04-23 |
2007-12-11 |
Medical Software, Llc |
Medical risk assessment method and program product
|
|
GB0411502D0
(en)
*
|
2004-05-22 |
2004-06-23 |
Britannia Pharmaceuticals Ltd |
Pharmaceutical compositions
|
|
US20060057215A1
(en)
*
|
2004-09-15 |
2006-03-16 |
Raiche Adrian T |
Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility
|
|
US20060057216A1
(en)
*
|
2004-09-15 |
2006-03-16 |
Salamone Joseph C |
Low-obscuration image transmitting particulate ocular therapeutic formulations
|
|
US7495052B2
(en)
*
|
2004-09-15 |
2009-02-24 |
Bausch & Lomb Incorporated |
Method for the production of polymerized nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility
|
|
CA2582403A1
(en)
*
|
2004-10-01 |
2006-04-13 |
Lifecycle Pharma A/S |
Pharmaceutical compositions comprising fenofibrate and atorvastatin
|
|
WO2006037345A1
(en)
*
|
2004-10-01 |
2006-04-13 |
Lifecycle Pharma A/S |
Pharmaceutical composition comprising fenofibrate and simvastatin
|
|
CA2589537A1
(en)
*
|
2004-12-02 |
2006-06-08 |
Stephen Craig Dyar |
Pharmaceutical compositions of amorphous atorvastatin and process for preparing same
|
|
BRPI0606883A2
(pt)
*
|
2005-02-10 |
2009-12-01 |
Lifecycle Pharma As |
composição farmacêutica para administração oral, método para preparar um tablete, e, forma de dosagem sólida única
|
|
DE102005011786A1
(de)
*
|
2005-03-11 |
2006-09-14 |
Pharmasol Gmbh |
Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
|
|
US20060223882A1
(en)
*
|
2005-03-23 |
2006-10-05 |
Venkataraman Sundaram |
Amorphous simvastatin
|
|
MX2007012124A
(es)
*
|
2005-03-30 |
2007-11-21 |
Teva Pharma |
Formulaciones mejoradas de fenofibrato.
|
|
US20070148233A1
(en)
*
|
2005-12-28 |
2007-06-28 |
Lerner E I |
Pharmaceutical formulations of fenofibrate having improved bioavailability
|
|
MX2007011858A
(es)
*
|
2005-03-30 |
2008-03-25 |
Teva Pharma |
Formulaciones mejoradas de fenofibrato que contienen mentol o peg/poloxamero.
|
|
WO2006084475A2
(en)
*
|
2005-04-13 |
2006-08-17 |
Lifecycle Pharma A/S |
A tablet comprising a fibrate
|
|
US20070015833A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Moshe Flashner-Barak |
Formulations of fenofibrate containing menthol
|
|
US20070015834A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Moshe Flashner-Barak |
Formulations of fenofibrate containing PEG/Poloxamer
|
|
CA2628666A1
(en)
*
|
2005-11-21 |
2007-05-24 |
Teva Pharmaceutical Industries Ltd. |
Atorvastatin formulation
|
|
EP1808162A1
(de)
*
|
2005-11-21 |
2007-07-18 |
Teva Pharmaceutical Industries Ltd. |
Pharmazeutische Formulierung von Atorvastatin
|
|
US20070148245A1
(en)
*
|
2005-12-22 |
2007-06-28 |
Ilan Zalit |
Compressed solid dosage forms with drugs of low solubility and process for making the same
|
|
PL1803441T3
(pl)
*
|
2005-12-28 |
2009-10-30 |
Teva Pharma |
Farmaceutyczne formulacje fenofibratu o polepszonej biodostępności
|
|
CA2634094A1
(en)
*
|
2005-12-28 |
2007-07-05 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical formulations of fenofibrate having improved bioavailability
|
|
US20070202159A1
(en)
*
|
2006-02-02 |
2007-08-30 |
Mathur Rajeev S |
Pharmaceutical composition comprising stabilized statin particles
|
|
WO2007100609A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Albert Einstein College Of Medicine Of Yeshiva University |
Electron transfer through glassy matrices
|
|
JP5566101B2
(ja)
|
2006-04-24 |
2014-08-06 |
メディカル・インスティル・テクノロジーズ・インコーポレイテッド |
針貫通可能かつレーザ再密閉可能な凍結乾燥装置およびこれに関連する方法
|
|
EP1870649A1
(de)
|
2006-06-20 |
2007-12-26 |
Octapharma AG |
Gefriertocknung zum Erzielen einer bestimmte Restfeuchte durch beschränkte Desorptionsenergiepegeln.
|
|
US7877895B2
(en)
|
2006-06-26 |
2011-02-01 |
Tokyo Electron Limited |
Substrate processing apparatus
|
|
MX2009000035A
(es)
*
|
2006-06-26 |
2009-05-28 |
Mutual Pharmaceutical Co |
Formulaciones de agente activo, procedimientos de preparacion y procedimientos de uso.
|
|
GB0613925D0
(en)
*
|
2006-07-13 |
2006-08-23 |
Unilever Plc |
Improvements relating to nanodispersions
|
|
SI2046292T1
(sl)
*
|
2006-07-21 |
2010-06-30 |
Novartis Ag |
Formulacije za benzimidazolil piridil etre
|
|
WO2008013416A1
(en)
*
|
2006-07-27 |
2008-01-31 |
Amorepacific Corporation |
Process for preparing powder comprising nanoparticles of sparingly soluble drug
|
|
WO2008064259A2
(en)
*
|
2006-11-21 |
2008-05-29 |
Biokey, Inc. |
Solid dispersion composition comprising fluvastatin
|
|
WO2008065502A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
|
|
US7908765B2
(en)
*
|
2006-12-22 |
2011-03-22 |
Collette Nv |
Continuous granulating and drying apparatus
|
|
US20080161594A1
(en)
*
|
2006-12-29 |
2008-07-03 |
Industrial Technology Research Institute |
Method for fabricating nanoparticles containing fenofibrate
|
|
US7872560B2
(en)
*
|
2007-03-19 |
2011-01-18 |
Abc Taiwan Electronics Corp. |
Independent planar transformer
|
|
US20100119612A1
(en)
*
|
2007-04-17 |
2010-05-13 |
Bend Research, Inc |
Nanoparticles comprising non-crystalline drug
|
|
WO2008135855A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
|
US8309129B2
(en)
*
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
|
US20100080852A1
(en)
*
|
2007-05-03 |
2010-04-01 |
Ronald Arthur Beyerinck |
Phamaceutical composition comprising nanoparticles and casein
|
|
US8974827B2
(en)
*
|
2007-06-04 |
2015-03-10 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
|
US20100215747A1
(en)
*
|
2007-07-13 |
2010-08-26 |
Corey Jay Bloom |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
SI2200588T1
(sl)
|
2007-09-25 |
2019-08-30 |
Solubest Ltd. |
Sestavki, ki obsegajo lipofilne aktivne spojine, in postopek za njihovo pripravo
|
|
EP2240162A4
(de)
*
|
2007-12-06 |
2013-10-09 |
Bend Res Inc |
Nanoteilchen mit einem nicht-ionisierbaren polymer und einem amin-funktionalisierten methacrylat-copolymer
|
|
US9724362B2
(en)
*
|
2007-12-06 |
2017-08-08 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
|
US20090182053A1
(en)
*
|
2007-12-19 |
2009-07-16 |
Tong Sun |
Fenofibric acid amorphous dispersion; method of making; and method of use thereof
|
|
US20090162434A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Disphar International Bv |
Mesalazine tablet
|
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
|
WO2010111132A2
(en)
|
2009-03-27 |
2010-09-30 |
Bend Research, Inc. |
Spray-drying process
|
|
JP2012523414A
(ja)
|
2009-04-09 |
2012-10-04 |
エンテグリオン、インコーポレイテッド |
噴霧乾燥した血液製剤とその製造方法
|
|
US20110142885A1
(en)
|
2009-09-16 |
2011-06-16 |
Velico Medical, Inc. |
Spray-dried human plasma
|
|
KR100980749B1
(ko)
|
2009-12-17 |
2010-09-07 |
삼일제약주식회사 |
페노피브레이트-함유 과립 및 이를 포함하는 약학 조성물
|
|
PT2611530T
(pt)
|
2010-09-03 |
2019-05-09 |
Bend Res Inc |
Aparelho de secagem por pulverização e métodos de utilização do mesmo
|
|
US9084976B2
(en)
|
2010-09-03 |
2015-07-21 |
Bend Research, Inc. |
Spray-drying apparatus and methods of using the same
|
|
CA2812061A1
(en)
|
2010-09-22 |
2012-03-29 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
EP2618924A1
(de)
|
2010-09-24 |
2013-07-31 |
Bend Research, Inc. |
Hochtemperatur-sprühtrocknungsverfahren und verfahren
|
|
US8877221B2
(en)
|
2010-10-27 |
2014-11-04 |
Warsaw Orthopedic, Inc. |
Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
|
|
US9107983B2
(en)
|
2010-10-27 |
2015-08-18 |
Warsaw Orthopedic, Inc. |
Osteoconductive matrices comprising statins
|
|
US9308190B2
(en)
|
2011-06-06 |
2016-04-12 |
Warsaw Orthopedic, Inc. |
Methods and compositions to enhance bone growth comprising a statin
|
|
BR112014025518B1
(pt)
|
2012-04-13 |
2022-05-24 |
Glaxosmithkline Intellectual Property Development Limited |
Partículas agregadas de umeclidinium, vilanterol e fluticasona, composição em pó, inalador, processo para a preparação de partículas agregadas, e, uso de estearato de magnésio em partículas agregadas
|
|
US8722083B2
(en)
|
2012-06-25 |
2014-05-13 |
Mylan, Inc. |
Fenofibrate formulation
|
|
US9439860B2
(en)
|
2012-06-25 |
2016-09-13 |
Mylan, Inc. |
Fenofibrate formulation
|
|
MX2013006332A
(es)
*
|
2013-06-05 |
2014-12-19 |
Alparis Sa De Cv |
Composiciones farmaceuticas orales para uso en dislipidemias.
|
|
EP2878311A1
(de)
*
|
2013-11-27 |
2015-06-03 |
Freund Pharmatec Ltd. |
Verbesserung der Löslichkeit für hydrophobe Wirkstoffe
|
|
PL3154528T3
(pl)
|
2014-06-11 |
2023-07-10 |
SpecGx LLC |
Suszone rozpyłowo kompozycje o różnych profilach rozpuszczania i sposoby ich wytwarzania
|
|
US9561184B2
(en)
|
2014-09-19 |
2017-02-07 |
Velico Medical, Inc. |
Methods and systems for multi-stage drying of plasma
|
|
CA2962719A1
(en)
|
2014-10-31 |
2016-05-06 |
Bend Research Inc. |
Process for forming active domains dispersed in a matrix
|
|
US11007175B2
(en)
|
2015-01-06 |
2021-05-18 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
|
KR102883123B1
(ko)
|
2015-06-22 |
2025-11-10 |
아레나 파마슈티칼스, 인크. |
S1p1 수용체-관련 장애에서의 사용을 위한 (r)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[b]인돌-3-일)아세트산 (화합물 1)의 결정성 l-아르기닌 염
|
|
MA47504A
(fr)
|
2017-02-16 |
2019-12-25 |
Arena Pharm Inc |
Composés et méthodes de traitement de l'angiocholite biliaire primitive
|
|
US10627161B2
(en)
*
|
2018-01-24 |
2020-04-21 |
King Abdulaziz City for Science and Technology (KACST) |
Laboratory equipment and method of using the same for drying a starting material to produce nano material
|
|
WO2019236757A1
(en)
|
2018-06-06 |
2019-12-12 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
|
WO2022183281A1
(en)
*
|
2021-03-03 |
2022-09-09 |
Mcmaster Christopher R |
Compounds and treatments for muscular dystrophy
|
|
USD1081739S1
(en)
|
2021-04-06 |
2025-07-01 |
Altria Client Services Llc |
Die for gum forming
|
|
US20220313678A1
(en)
*
|
2021-04-06 |
2022-10-06 |
Altria Client Services Llc |
Spray dried nicotine for inclusion in oral products
|
|
WO2024059770A1
(en)
|
2022-09-15 |
2024-03-21 |
Velico Medical, Inc. |
Rapid spray drying system
|
|
US11998861B2
(en)
|
2022-09-15 |
2024-06-04 |
Velico Medical, Inc. |
Usability of a disposable for a spray drying plasma system
|
|
US12083447B2
(en)
|
2022-09-15 |
2024-09-10 |
Velico Medical, Inc. |
Alignment of a disposable for a spray drying plasma system
|
|
US12246093B2
(en)
|
2022-09-15 |
2025-03-11 |
Velico Medical, Inc. |
Methods for making spray dried plasma
|
|
US12246266B2
(en)
|
2022-09-15 |
2025-03-11 |
Velico Medical, Inc. |
Disposable for a spray drying system
|
|
US11975274B2
(en)
|
2022-09-15 |
2024-05-07 |
Velico Medical, Inc. |
Blood plasma product
|
|
US11841189B1
(en)
|
2022-09-15 |
2023-12-12 |
Velico Medical, Inc. |
Disposable for a spray drying system
|
|
US20240131236A1
(en)
*
|
2022-09-15 |
2024-04-25 |
Velico Medical, Inc. |
Dryer For A Spray Drying System
|